PDS Biotechnology Corporation (PDSB)
PDSB Stock Price Chart
Explore PDS Biotechnology Corporation interactive price chart. Choose custom timeframes to analyze PDSB price movements and trends.
PDSB Company Profile
Discover essential business fundamentals and corporate details for PDS Biotechnology Corporation (PDSB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Sept 2015
Employees
24.00
Website
https://www.pdsbiotech.comCEO
Frank K. Bedu-Addo
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
PDSB Financial Timeline
Browse a chronological timeline of PDS Biotechnology Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.21.
Earnings released on 13 Aug 2025
EPS came in at -$0.21 surpassing the estimated -$0.24 by +12.50%.
Earnings released on 14 May 2025
EPS came in at -$0.21 surpassing the estimated -$0.25 by +16.00%.
Earnings released on 27 Mar 2025
EPS came in at -$0.21 surpassing the estimated -$0.29 by +27.59%.
Earnings released on 14 Nov 2024
EPS came in at -$0.29 matching the estimated -$0.29.
Earnings released on 13 Aug 2024
EPS came in at -$0.23 surpassing the estimated -$0.31 by +25.81%.
Earnings released on 15 May 2024
EPS came in at -$0.30 surpassing the estimated -$0.37 by +18.92%.
Earnings released on 27 Mar 2024
EPS came in at -$0.34 surpassing the estimated -$0.39 by +12.82%.
Earnings released on 14 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.42 by +16.67%.
Earnings released on 14 Aug 2023
EPS came in at -$0.37 matching the estimated -$0.37.
Earnings released on 15 May 2023
EPS came in at -$0.32 falling short of the estimated -$0.31 by -3.23%.
Earnings released on 28 Mar 2023
EPS came in at -$0.67 falling short of the estimated -$0.30 by -123.33%.
Earnings released on 14 Nov 2022
EPS came in at -$0.26 matching the estimated -$0.26.
Earnings released on 8 Aug 2022
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%.
Earnings released on 11 May 2022
EPS came in at -$0.32 .
Earnings released on 31 Mar 2022
EPS came in at -$0.23 surpassing the estimated -$0.24 by +4.17%.
Earnings released on 10 Nov 2021
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%.
Earnings released on 12 Aug 2021
EPS came in at -$0.22 falling short of the estimated -$0.21 by -4.76%.
Earnings released on 13 May 2021
EPS came in at -$0.14 surpassing the estimated -$0.20 by +30.00%.
Earnings released on 18 Mar 2021
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%.
Earnings released on 11 Nov 2020
EPS came in at -$0.23 falling short of the estimated -$0.14 by -64.29%.
PDSB Stock Performance
Access detailed PDSB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.